Koichi Furukawa Selected Research

Koichi Furukawa Research Topics

Disease

41	Neoplasms (Cancer) 01/2023 - 07/2002
27	Melanoma (Melanoma, Malignant) 01/2023 - 03/2003
11	Inflammation (Inflammations) 03/2020 - 12/2009
8	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2003
8	COVID-19 07/2023 - 01/2021
8	Glioma (Gliomas) 01/2023 - 05/2004
8	Guillain-Barre Syndrome 01/2012 - 09/2002
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 07/2002
6	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 08/2009
6	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2003
5	Infections 09/2023 - 09/2002
3	Astrocytoma (Pilocytic Astrocytoma) 01/2023 - 05/2004
3	Pain (Aches) 05/2022 - 10/2005
3	Nervous System Diseases (Neurological Disorders) 08/2020 - 01/2019
3	Kidney Neoplasms (Kidney Cancer) 04/2020 - 03/2007
3	Colonic Neoplasms (Colon Cancer) 12/2019 - 06/2003
3	Neuroblastoma 04/2018 - 08/2003
3	Rheumatoid Arthritis 04/2016 - 01/2016
3	Arthritis (Polyarthritis) 04/2016 - 01/2016
3	Hyperalgesia 10/2011 - 10/2005
2	Squamous Cell Carcinoma of Head and Neck 04/2021 - 08/2013
2	Cytokine Release Syndrome 01/2021 - 04/2002
2	Hereditary Spastic Paraplegia 08/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 04/2016
2	Experimental Arthritis 04/2016 - 01/2016
2	Lymphoma (Lymphomas) 01/2016 - 08/2003
2	Osteosarcoma (Osteogenic Sarcoma) 12/2012 - 09/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012 - 09/2011
2	Myalgia 10/2011 - 11/2008
2	Fabry Disease (Fabry's Disease) 02/2011 - 09/2009
2	Paralysis (Palsy) 02/2005 - 08/2004
2	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 06/2003 - 12/2002
1	Human Influenza (Influenza) 09/2023
1	Virus Diseases (Viral Diseases) 09/2023
1	autosomal recessive Spastic paraplegia 26 01/2023
1	Insulin Resistance 01/2023

Drug/Important Bio-Agent (IBA)

46	GangliosidesIBA 01/2023 - 09/2002
21	GD3 ganglioside (GD(3))IBA 01/2023 - 03/2003
14	AntigensIBA 01/2022 - 03/2003
13	AntibodiesIBA 09/2023 - 03/2003
12	GlycolipidsIBA 01/2022 - 05/2004
12	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2019 - 08/2003
11	GlycosphingolipidsIBA 05/2019 - 08/2003
10	EnzymesIBA 12/2021 - 01/2002
8	LipidsIBA 09/2023 - 06/2006
7	Messenger RNA (mRNA)IBA 01/2023 - 03/2002
7	GD2 gangliosideIBA 01/2023 - 07/2002
7	Complement System Proteins (Complement)IBA 03/2020 - 12/2009
7	Complementary DNA (cDNA)IBA 12/2019 - 01/2003
6	IntegrinsIBA 12/2021 - 08/2005
6	CytokinesIBA 08/2021 - 09/2009
6	Immunoglobulin G (IgG)IBA 01/2021 - 08/2004
6	PaxillinIBA 08/2016 - 08/2005
6	Monoclonal AntibodiesIBA 04/2016 - 07/2002
5	CarbohydratesIBA 01/2022 - 01/2003
4	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 01/2023 - 01/2003
3	EpitopesIBA 09/2023 - 01/2008
3	Neutralizing AntibodiesIBA 01/2022 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 11/2021 - 08/2009
3	Epidermal Growth Factor (EGF)IBA 04/2021 - 10/2013
3	SugarsIBA 01/2021 - 01/2008
3	GlycosyltransferasesIBA 08/2020 - 03/2014
3	LectinsIBA 12/2019 - 12/2013
3	LigandsIBA 12/2019 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 10/2017 - 05/2011
3	Tn antigenIBA 10/2016 - 03/2012
3	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2016 - 03/2008
3	UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferaseIBA 04/2016 - 03/2002
3	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 07/2004
3	Phosphotransferases (Kinase)IBA 06/2015 - 07/2002
3	OligosaccharidesIBA 01/2010 - 09/2002
3	AutoantibodiesIBA 03/2009 - 09/2002
3	Tyrosine (L-Tyrosine)FDA Link 08/2008 - 11/2006
3	SialyltransferasesIBA 03/2007 - 06/2003
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 10/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 10/2022
2	Peptides (Polypeptides)IBA 11/2021 - 09/2016
2	src-Family KinasesIBA 09/2021 - 05/2011
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 09/2021 - 06/2015
2	A-Form DNA (A-DNA)IBA 09/2021 - 08/2013
2	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 08/2006
2	ChemokinesIBA 08/2021 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 05/2019 - 08/2008
2	Small Interfering RNA (siRNA)IBA 08/2016 - 03/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 03/2014
2	Syndecan-1 (Syndecan 1)IBA 08/2013 - 03/2012
2	globotriaosylceramide (globotriosylceramide)IBA 02/2011 - 09/2009
2	Histones (Histone)IBA 06/2008 - 07/2004
2	Caveolin 1IBA 04/2007 - 08/2006
2	GalNAc sialyltransferase VIIBA 03/2007 - 06/2003
2	G(M1) GangliosideIBA 06/2006 - 08/2004
2	LipopolysaccharidesIBA 07/2004 - 09/2002
1	Vaccine AdjuvantsIBA 09/2023
1	VaccinesIBA 07/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Decitabine FDA Link 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 10/2022

Therapy/Procedure

12	Therapeutics 08/2020 - 04/2002
4	Immunotherapy 01/2022 - 08/2008
1	Precision Medicine 04/2024